Neurothrombectomy Devices Market To Reach $1.1 Billion By 2030

Neurothrombectomy Devices Market Growth & Trends

The global neurothrombectomy devices market size is expected to reach USD 1.1 billion by 2030, registering a CAGR of 6.94% from 2025 to 2030, according to a new report by Grand View Research, Inc. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.

Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.

 Request a free sample copy or view report summary: Neurothrombectomy Devices Market Report

Neurothrombectomy Devices Market Report Highlights

• Based on products, clot retrievers segment dominated the market in 2024, with a share of 57.8% owing to the rising prevalence of acute ischemic stroke and an increasing number of product launches by key market players.

• Based on end-use, hospital segment dominated the market in 2024 with a share of 70.4% due to improving health care facilities and the availability of advanced equipment in the hospitals.

• Europe led the market with the maximum revenue share of 32.9% in 2024, owing to the increasing number of patients suffering from acute ischemic stroke in this region.

Neurothrombectomy Devices Market Segmentation

Grand View Research has segmented the global neurothrombectomy devices market based on product, end use and region:

Neurothrombectomy Devices Product Outlook (Revenue USD Million; 2018 - 2030)

• Clot Retrievers

• Aspiration/ Suction Devices

• Vascular Snares

Neurothrombectomy Devices End Use Outlook (Revenue USD Million; 2018 - 2030)

• Hospital

• Emergency Clinics

• Ambulatory Surgical Centers

Neurothrombectomy Devices Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

  • Colombia

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Neurothrombectomy Devices Market 

• Medtronic

• Stryker Corporation

• Acandis GmbH

• Phenox GmbH

• Penumbra Inc.

• Vesalio